PL EN


Preferences help
enabled [disable] Abstract
Number of results
2014 | 4 | 2 | 11-19
Article title

Comparison of the clinical status and the effects of treatment of newborns with interrupted aortic arch diagnosed prenatally and postnatally in the "Polish Mother's Memorial" Institute in Lodz in the years 2003-2012

Content
Title variants
Languages of publication
EN
Abstracts
EN
Material and Methods: A retrospective analysis of 41 patients with congenital heart defect IAA from ICZMP in Lodz in the years 2003-2012, including 15 (36.6%) after prenatal diagnosis. Results: An average of 4 newborns with IAA were operated annually, in the years 2003 -2009 postnatal diagnosis dominated, from 2010 prenatal diagnosis. In the group, n = 15 fetuses with IAA, heart size was normal: Avg 0.33 + / -0.05 HA / CA. Cardiovascular endurance in the CVPS : 8 - 10 points Avg. 9.56 + / -0.73. Infants in the "prenatal" group were often delivered by CS (64.3%), and infants diagnosed postnatally, often by spontaneous delivery (76.9%). In the prenatal group 100% of newborns received prostaglandin E1 from day one, and the "postnatal" group at an average of 6th day. In the "prenatal" group the dose of PGE: 0.02 ug / kg / min, in the "postnatal" group the average dose was> 2 x higher 0,042 mg / kg / min. A statistically significant relationship was shown: between the day of administering prostaglandin E1 and the number of postoperative recovery hospitalization days of the newborn with IAA. Di George Syndrome occurred in 40% in the "prenatal" and in 15.4% in the "postnatal" group. Cardiac operations in the "prenatal" group were performed at average 19th day, and at average 21st day in the "postnatal" group. Infants in the "prenatal" group remained in the postoperative recovery room an average of 7.85 + / -3.98 days, and those from the “postnatal” group an average of 8.38 + / -3.94 days (p = 0.6212). There were 3 deaths (7.3%): 1 patient diagnosed prenatally and 2 postnatally. Neonates with IAA in the "prenatal" group remained in the hospital on average: 43.69 + / - 4.82 days and 39.54 + / -3.75 days in the "postnatal" group. After cardiac surgery, hospitalization in the "prenatal" group amounted to an average of 25.2 days in the "postnatal" 26.7 days. Conclusions: 1. The prenatal diagnosis of IAA was grounds to start the administration of prostaglandin E1 on the first day of life, and in the "postnatal" group the administration of prostaglandin followed on average 6 days after birth, the "postnatal" dose was 2 x higher. 2. A statistically significant correlation was demonstrated between the day of prostaglandin E1 commencement and the number of hospitalization days of the newborn with IAA in the postoperative recovery room, the length of hospital stay in the ICU and sometimes full hospitalization.
Publisher

Year
Volume
4
Issue
2
Pages
11-19
Physical description
Dates
published
1 - 6 - 2014
online
30 - 12 - 2015
accepted
30 - 6 - 2014
received
4 - 5 - 2014
Contributors
  • Subdivision of Anesthesiology and Intensive Care, Pediatric Department of Anesthesiology and Intensive Care Medicine, Polish Mother’s Memorial Hospital Research Institute
  • Department of Prenatal Cardiology, Polish Mother’s Memorial Hospital Research Institute
  • Institute of Health Sciences. The State School of Higher Professional Education in Płock
  • Department of Anesthesiology and Int Medical Therapy
author
  • Cardiosurgery Department, Polish Mother’s Memorial Hospital Research Institute
  • Department of Prenatal Cardiology, Polish Mother’s Memorial Hospital Research Institute
  • Department of Diagnoses and Prevention Fetal Malformations Medical University of Lodz
References
  • 1. Skalski J, Religa Z. Kardiochirurgia dziecięca. Wydawnictwo Naukowe Śląsk, Katowice 2003.
  • 2. Malec E, Januszewska K, Radziwiłłowa D, Pawłowska M. Dziecko z wadą serca. Poradnik dla rodziców. Fundacja im. Diny Radziwiłłowej, Warszawa 2007.
  • 3. Dillman J, Yarram S, D’Amico A, i wsp. Interrupted Aortic Arch. Spectrum of MRI Findings. American Journal of Roentgenology 2008;6(190):1467-1474.[Crossref]
  • 4. Szczeklik A, Tender M. Kariologia. Podręcznik oparty na zasadach EBM. Tom I. Wyd. Medycyna praktyczna, Kraków 2009.
  • 5. Kimura-Hayama E, Melendez G, Mendizabal A, i wsp. Uncommon Congenital and Acquired Aortic Diseases. Role of Multidetector CT Angiography. RadioGraphics 2010;1(30):79-98.[WoS][Crossref]
  • 6. Szymkiewicz-Dangel J. Krytyczne wady serca - diagnostyka prenatalna. Standardy Medyczne. Pediatria 2008;5:294-298.
  • 7. Dryżek P, Politowska B, Moszura T, i wsp. Rzadkie postaci przerwanego łuku aorty - trudności diagnostyczne. Opis dwóch przypadków. Polski Przegląd Kardiologiczny 2010;4(12):325-328.
  • 8. Niszczota C, Koleśnik A. Embriogeneza i morfologia wad łuku aorty. Pediatria Polska 2013; 2(88):80-91.[Crossref]
  • 9. Respondek-Liberska M. Kardiologia prenatalna dla położników i kardiologów dziecięcych. Wydawnictwo CZELEJ, Lublin 2006.
  • 10. Słodki M, Rychik J, Moszura T, i wsp. Measurement of the Great Vessels in the Mediastinum Could Help Distinguish True From False- Positive Coarctation of the Aorta in the Third Trimester. Journal of Ultrasound in Medicine 2009;10(28):1313-1317.
  • 11. Słodki M, Janiak K, Foryś S, i wsp. Przerwany łuk aorty u płodu - opis przypadku. Ultrasonografia 2012;48:109-111.
  • 12. Słodki M, Moszura T, Janiak K, i wsp. The three-vessel view in the fetal mediastinum in the diagnosis of interrupted aortic arch. Ultrasound In Medicine & Biology 2011;11(37):1808-1813.[WoS]
  • 13. Stańczyk J, Kierzkowska B, Kowalska-Koprek U, i wsp. Zastosowanie diagnostyki prenatalnej w wykrywaniu wrodzonych wad serca - ocena wybranych parametrów echokardiograficznych. Ginekologia Polska 2005;11(76):890-897.
  • 14. Axt-Fliedner R, Kawecki A, Enzensberger C, i wsp. Fetal and Neonatal Diagnosis of Interrupted Aortic Arch. Associations. Fetal Diagnosis and Therapy 2011;4(30):299-305.[WoS]
  • 15. Volpe P, Tuo G, De Robertis V, i wsp. Fetal interrupted aortic arch: 2D-4D echocardiography, associations and outcome. Ultrasound in Obstetrics & Gynecology 2010;3(35):302-309.[WoS]
  • 16. Respondek-Liberska M, Janiak K. Protokół badania kardiologicznego u płodu w ośrodku referencyjnym. Polski Przegląd Kardiologiczny 2010;3(12):212-218.
  • 17. Volpe P, Marasini M, Caruso G, i wsp. Prenatal diagnosis of interrupted of the aortic arch and its association with deletion of chromosome 22q11. Ultrasound in Obstetrics & Gynecology2002;4(20):327-331.
  • 18. Govindaswami B, Jegatheesan P, i wsp. Oxygen Saturation Screening for Criitical Congenital Heart Disease. NeoReviews 2012;12(13):724-731.[Crossref]
  • 19. Altman C. Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD
  • 20. http://www.uptodate.com/contents/congenital-heart-diseasechdin-the-newborn-presentation-and-screening-for-critical-chd
  • 21. Ewer A, i wsp. Pulse oximetry as a screening test for congenital heart defects in newborn infants. A test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technology Assessment 2012;2(16)[WoS]
  • 22. Nowy podział wad serca płodu na 4 grupy, wg www.orpkp.pl
  • 23. Respondek-Liberska M. Nowy Podział wad serca u płodu (z punktu widzenia kardiologii prenatalnej) http://www.gazetalekarska.pl/xml/nil/gazeta/numery/n2012/n201205/n2020513
  • 24. Respondek-Liberska M. Atlas wad serca u płodu. Wybór patologii pod kątem ich znaczenia klinicznego. Wydawnictwo ADI, Łódź 2011.
  • 25. Słodki M. Opracowanie modelu opieki nad ciężarną z wrodzoną wadą serca u płodu na podstawie nowego prenatalnego podziału wad serca. Rozprawa habilitacyjna. Łódź 2012.
  • 26. Vogel M, Vernon MM, McElhinney DB, i wsp. Fetal diagnosis of interrupted aortic arch. The American Journal of Cardiology 2010;5(105):727-734.[WoS][Crossref]
  • 27. Wieczorek A. Prediction of outcome of fetal congenital heart disease using a cardiovascular profile score. Ultrasound in Obstetrics and Gynecology 2008;3(31):284-288.
  • 28. Morales D, Scully P, i wsp. Interrupted Aortic Arch Repair. Aortic Arch Advancement Without a Patch Minimizes Arch Reinterventions. The Annals of Thoracic Surgery 2006;5(82):1577-1584.
  • 29. Serraf A, i wsp. Repair of interrupted aortic arch: a ten-year experience. The Journal of Thoratic and Cardiovascular Surgery 1996;5(112):1150-1160.
  • 30. Jacobs M, Chin A, i wsp. Interrupted Aortic Arch Impact of Subaortic Stenosis on Management and Outcome. Circulation 1995;92:128-131.[Crossref]
  • 31. McCrindle B, Tchervenkov Ch, i wsp. Risk factors associated with mortality and interventions in 472 neonates with interrupted aortic arch. A Congenital Heart Surgeons Society Study. The Journal of Thoratic and Cardiovascular Surgery 2005; 2(129):343-350.
  • 32. Pan J, Hsieh K, i wsp. Complete Repair of Iterrupted Aortic Arch with Ventricular Septal Defect In a Premature Weighing 1600 Grams - A Case Report. Acta Cardiolodigica Sinica 2005;21:54-57.
  • 33. Lacour-Gayet i wsp. Ross-Konno Procedure in Neonates. Report Of Three Patients. The Society of Thoracic Surgeons 2004;77:2223-2225.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_12847_06142
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.